TABLE 6.
Fold enrichment | P value | |
---|---|---|
fWBI, dorsolateral prefrontal cortex | ||
aPlatelet-derived growth factor binding | >100.00 | 2.96E–04 |
fWBI, white matter | ||
Tumor necrosis factor binding | >100.00 | 5.93E–03 |
aPlatelet-derived growth factor binding | >100.00 | 6.18E–06 |
Interleukin-1 receptor activity | >100.00 | 1.80E–02 |
Tumor necrosis factor-activated receptor activity | 99.63 | 1.50E–06 |
aPlatelet-derived growth factor receptor binding | 95.65 | 1.16E–03 |
Phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 43.48 | 2.51E–06 |
bExtracellular matrix structural constituent | 42.92 | 5.27E–07 |
bIntegrin binding | 29.62 | 1.85E–06 |
bProtease binding | 24.98 | 3.89E–06 |
bCollagen binding | 22.77 | 3.80E–02 |
Notes. Analyses completed in Gene Ontology enrichment analysis tool. Maximum fold-enrichment values are truncated at 100. The top 10 enriched ontologies are reported in order of decreasing fold-enrichment and statistical significance, multiplicity adjusted P values ≤ 0.05 were considered significant. Overarching molecular function:
Platelet derived growth factor (PDGF) signaling
ECM remodeling.